Another study finds atypicals risky

Atypical antipsychotic double patients' risk of dying from sudden heart failure, a study has found. It's the latest in a succession of reports contradicting the long-held assumption that the new drugs--which include Johnson & Johnson's Risperdal, Eli Lilly's Zyprexa and AstraZeneca's Seroquel--are safer than the older and much less expensive medications that they replaced. Report

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.